| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0008-6363(00)00231-5 |
| P698 | PubMed publication ID | 11166279 |
| P2093 | author name string | Stewart DJ | |
| Alitalo K | |||
| Yancopoulos GD | |||
| Jones N | |||
| Campbell AI | |||
| Maisonpierre PC | |||
| Teichert-Kuliszewska K | |||
| Bendeck MP | |||
| Dumont DJ | |||
| Master Z | |||
| P433 | issue | 3 | |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 659-670 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. | |
| P478 | volume | 49 |
| Q35083718 | A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice |
| Q31110832 | A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors |
| Q24684919 | A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function |
| Q44550685 | Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis |
| Q36421349 | Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-amniotic infection/inflammation |
| Q40646268 | Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide |
| Q85055700 | Angiogenic therapy for cardiac repair based on protein delivery systems |
| Q35677326 | Angiopoeitin-2 modulates Survivin expression in OxLDL-induced endothelial cell apoptosis. |
| Q44466129 | Angiopoietin 1 and angiopoietin 2 are associated with medial thickening of hepatic arterial branches in biliary atresia. |
| Q24311749 | Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium |
| Q28287317 | Angiopoietin signaling in the vasculature |
| Q35587117 | Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma |
| Q28214611 | Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats |
| Q35103148 | Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease. |
| Q48330774 | Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement |
| Q48508330 | Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia |
| Q34121752 | Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide. |
| Q34037478 | Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo |
| Q35070344 | Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells |
| Q33897226 | Angiopoietin-2 in experimental colitis |
| Q39317367 | Angiopoietin-2 inhibition using siRNA or the peptide antagonist L1-10 results in antitumor activity in human neuroblastoma |
| Q44166149 | Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. |
| Q51739287 | Angiopoietin-2 promoter haplotypes confer an increased risk of stroke in a Chinese Han population. |
| Q44654332 | Angiopoietin/Tek Interactions Regulate MMP-9 Expression and Retinal Neovascularization |
| Q91637742 | Angiopoietin/Tie2 Axis Regulates the Age-at-Injury Cerebrovascular Response to Traumatic Brain Injury |
| Q36489760 | Angiopoietins and angiopoietin-like proteins in angiogenesis |
| Q24323888 | Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts |
| Q49967364 | Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor. |
| Q35075339 | Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy |
| Q34451437 | Angiopoietins, abdominal aortic aneurysm and atherosclerosis |
| Q36470562 | BLOCKADE OF ENDOTHELIAL GROWTH FACTOR, ANGIOPOIETIN-2, REDUCES INDICES OF ARDS AND MORTALITY IN MICE RESULTING FROM THE DUAL-INSULTS OF HEMORRHAGIC SHOCK AND SEPSIS. |
| Q37478709 | Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target? |
| Q24300341 | Biological characterization of angiopoietin-3 and angiopoietin-4 |
| Q37846342 | Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance? |
| Q28588612 | Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo |
| Q92158428 | Cigarette Smoke Induced Lung Barrier Dysfunction, EMT, and Tissue Remodeling: A Possible Link between COPD and Lung Cancer |
| Q89644187 | Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies |
| Q42598438 | Colorectal resection, both open and laparoscopic-assisted, in patients with benign indications is associated with proangiogenic changes in plasma angiopoietin 1 and 2 levels |
| Q24644150 | Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels |
| Q37398561 | Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system |
| Q36452714 | Current status and perspective of antiangiogenic therapy for cancer: urinary cancer |
| Q36696063 | Differential expression of growth-, angiogenesis- and invasion-related factors in the development of placenta accreta |
| Q24324013 | Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1 |
| Q33277127 | Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2. |
| Q42429806 | Dissecting the role of human embryonic stem cell-derived mesenchymal cells in human umbilical vein endothelial cell network stabilization in three-dimensional environments |
| Q24535902 | Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak. |
| Q36831553 | Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages. |
| Q44166133 | Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis |
| Q28585009 | Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice |
| Q39152895 | Effects of placental tissue secretory products on the formation of vascular tubules by EA.Hy926 endothelial cells. |
| Q25255098 | Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans |
| Q37157213 | Exercise training and peripheral arterial disease |
| Q46524956 | Exercise training contributes to H2O2/VEGF signaling in the lung of rats with monocrotaline-induced pulmonary hypertension. |
| Q43240480 | Expression and release of angiopoietin-1 from human neutrophils: intracellular mechanisms |
| Q33866067 | Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma |
| Q47744102 | High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice |
| Q24320033 | Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors |
| Q35415210 | Implantation of fibrin gel on mouse lung to study lung-specific angiogenesis |
| Q80964838 | Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown |
| Q35906308 | Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2. |
| Q37747100 | Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden |
| Q34981750 | Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2 |
| Q48872237 | Intravenous Injection of Clinical Grade Human MSCs After Experimental Stroke: Functional Benefit and Microvascular Effect. |
| Q38659074 | Lack of efficacy of combined antiangiogenic therapies in xenografted human melanoma |
| Q80252518 | Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis |
| Q24815394 | Modulation of extracellular matrix genes reflects the magnitude of physiological adaptation to aerobic exercise training in humans |
| Q35747405 | Molecular profiling of angiogenic markers: a step towards interpretive analysis of a complex biological function |
| Q24300714 | Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2 |
| Q37596104 | Neutrophil-endothelial interactions mediate angiopoietin-2-associated pulmonary endothelial cell dysfunction in indirect acute lung injury in mice |
| Q37217491 | Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation |
| Q92151830 | Pericytes in Microvessels: From "Mural" Function to Brain and Retina Regeneration |
| Q36695062 | Pericytes on the tumor vasculature: jekyll or hyde? |
| Q81272067 | Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study |
| Q37428029 | Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. |
| Q35544474 | Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma |
| Q42426145 | Regulation of Angiogenic Functions by Angiopoietins through Calcium-Dependent Signaling Pathways. |
| Q35789129 | Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting |
| Q40515324 | Regulation of tie2 expression by angiopoietin--potential feedback system |
| Q40510010 | Role of Ang1 and its interaction with VEGF-A in astrocytomas |
| Q92163068 | Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology |
| Q33689659 | Role of angiopoietin-2 in corneal lymphangiogenesis |
| Q40495040 | Role of angiopoietin-2 in regulating growth and vascularity of astrocytomas |
| Q35159581 | Role of the angiopoietin/Tie system in pregnancy (Review). |
| Q38265176 | Signaling Network Map of Endothelial TEK Tyrosine Kinase. |
| Q36462707 | Signaling and functions of angiopoietin-1 in vascular protection. |
| Q35562736 | Sildenafil ameliorates long term peripheral neuropathy in type II diabetic mice |
| Q39302290 | Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis |
| Q35092548 | Suppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody |
| Q35083402 | Targeting the Tie2/Tek receptor in astrocytomas. |
| Q43202086 | Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release. |
| Q47156884 | The Levels of Circulating Proangiogenic Factors in Migraineurs. |
| Q42121099 | The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice |
| Q37109566 | The angiopoietin/Tie2 axis mediates malignant pleural effusion formation |
| Q36186523 | The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway |
| Q36429528 | The dynamic roles of angiopoietins in tumor angiogenesis |
| Q28191178 | The enigmatic role of angiopoietin-1 in tumor angiogenesis |
| Q35299351 | The impact of anti-angiogenic agents on cancer therapy |
| Q37734546 | The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development |
| Q42161605 | The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression |
| Q34393516 | Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic mice |
| Q34205564 | Tie receptors: new modulators of angiogenic and lymphangiogenic responses |
| Q30805233 | Tie1 controls angiopoietin function in vascular remodeling and inflammation |
| Q38829065 | Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling |
| Q34437834 | Tie2-dependent neovascularization of the ischemic hindlimb is mediated by angiopoietin-2. |
| Q39403862 | Tumor angiogenesis and vascular normalization: alternative therapeutic targets |
| Q24312102 | Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells |
| Q36808641 | Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. |
| Q24311848 | VE-PTP controls blood vessel development by balancing Tie-2 activity |
| Q24644976 | VE-statin, an endothelial repressor of smooth muscle cell migration |
| Q45250508 | Vascular-specific growth factor angiopoietin 1 is involved in the organization of neuronal processes |
| Q30497797 | Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity |
Search more.